UCB Pharma (United States)

545 papers and 13.2k indexed citations i.

About

In recent decades, authors affiliated with UCB Pharma (United States) have published 545 papers, which have received a total of 13.2k indexed citations. Scholars at this organization have produced 200 papers in Psychiatry and Mental health, 187 papers in Pediatrics, Perinatology and Child Health and 155 papers in Immunology on the topics of Epilepsy research and treatment (185 papers), Pharmacological Effects and Toxicity Studies (165 papers) and Psoriasis: Treatment and Pathogenesis (107 papers). Their work is cited by papers focused on Psychiatry and Mental health (5.2k citations), Pediatrics, Perinatology and Child Health (4.6k citations) and Rheumatology (3.5k citations). Authors at UCB Pharma (United States) collaborate with scholars in United States, Belgium and Germany and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet. Some of UCB Pharma (United States)'s most productive authors include Martin Johnson, Philip J. Mease, Désirée van der Heijde, Victor Biton, Ronald van Vollenhoven, Linda Kalilani, Bassel Abou‐Khalil, Ilo E. Leppik, Sarah Lu and James J. Cereghino.

In The Last Decade

Fields of papers published by authors at UCB Pharma (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with UCB Pharma (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with UCB Pharma (United States) at the time of their publication.

Countries citing scholars working at UCB Pharma (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at UCB Pharma (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at UCB Pharma (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites UCB Pharma (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact